missing translation for 'onlineSavingsMsg'
Learn More

Invitrogen™ Human VKORC1 Synthetic Peptide

Numéro de catalogue. PEP1401
Modifier l'affichage
Click to view available options
Quantité:
50 μg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Numéro de catalogue. Quantité
PEP1401 50 μg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Numéro de catalogue. PEP1401 Fournisseur Invitrogen™ Code fournisseur PEP1401

Synthetic Peptide

VKORC1 Synthetic Peptide, PEP-1401, from Invitrogen.

Vitamin K epoxide reductase complex subunit 1 (VKORC1) is the enzyme that is responsible for reducing vitamin K 2,3-epoxide to the enzymatically activated form which is essential for blood clotting. This enzymatically activated form of vitamin K is a reduced form required for the carboxylation of glutamic acid residues in some blood-clotting proteins. Fatal bleeding can be caused by vitamin K deficiency and by the vitamin K antagonist warfarin, and it is VKORC1 that is sensitive to warfarin. In humans, mutations in this gene can be associated with deficiencies in vitamin-K-dependent clotting factors and, in humans and rats, with warfarin resistance.

Spécifications

ID du gène (Entrez) 79001
Espèces Human
Méthode de purification purified
Numéro d'enregistrement Q9BQB6
Nom usuel Human VKORC1
Concentration 200 μg/mL
Contenu et stockage -20°C
Aperçu général Synthetic Peptide
Format Liquid
Formule PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2
À utiliser avec (application) Blocking Assay, Control
Symbole de gène VKORC1
Lyophilisé No
Conservateur 0.02% sodium azide
Type de produit Peptide
Quantité 50 μg
Statut réglementaire RUO - research use only
Tampon de stockage PBS
Afficher plus de résultats Afficher moins de résultats